Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

Jun

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu

Aetna, Interpace Diagnostics Ink Coverage Agreement for Thyroid Assay

To read the full story....

Breaking News

At ESHG, Researchers Present New Noninvasive Prenatal Tests, Disease Recurrence Risk Study

USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

In Brief This Week: SpeeDx, Abbott

Bio-Techne Gets New York State Approval for Prostate Cancer Test

FDA Issues Draft Recommendations For Biotin Interference Testing

FDA Clears Roche Extraction Platform For Use With Applied BioCode GI Pathogen Panel, System

Error-Corrected Sequencing to Detect Measurable Residual Disease in Post-Transplant MDS Cases

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

What's Popular?

USPTO Denies Foundation Medicine Attempt to Invalidate Guardant Health Patent

Bio-Techne Gets New York State Approval for Prostate Cancer Test

ASCO Data Pushes Boundaries for Genomic Testing in Localized Breast Cancer

HPV Antibodies Can Be Detected 28 Years Before Virus-Linked Cancer Diagnosis, Study Finds

Saga Diagnostics Raises $4.2M

Sponsorships